Astellas Pharma Inc (YPH)
Market Open
15 Jun, 06:01
€
11. 90
+0.1
+0.8475%
€
21.86B Market Cap
152.62 P/E Ratio
78% Div Yield
425 Volume
0.14 Eps
€ 11.8
Previous Close Want to track YPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Astellas Pharma Inc (YPH) Statistics
Valuation metrics
Market Cap 21.86B
Enterprise value 1.67B
Trailing P/E (ttm) 13.86
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 0.01
Price/Book (mrq) 2.21
Enterprise Value/Revenue 0.14
Enterprise Value/EBITDA 0.54
Overview
Shares outstanding 1.79B
Float 1.79B
Shares short -
% Held by insiders 0%
% Held by institutions 0.57%
Average volume (10 days) 250
Average volume (90 days) 448
Price summary
52-Week low 7.85
52-Week high 14.19
Beta 0.08
50-Day moving average 13
200-Day moving average 11.27
Dividends and splits
Forward annual dividend rate 0.42
Forward annual dividend yield 0.0346%
Trailing annual dividend rate 0.42
Trailing annual dividend yield 0.0346%
5-Year annual dividend yield 3.6%
Payout ratio 0.48
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor 5:1
Last split Date 27 Mar 2014
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.14%
Operating margin 0.17%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.17%
Income Statement
Revenue (ttm) 11.58B
Revenue per share (ttm) 1,194.37
Quarterly revenue growth (yoy) 0.21%
Gross profit (ttm) 9.37B
EBITDA 3.11B
Net income to common (ttm) 1.58B
Diluted EPS (ttm) 0.88
Quarterly earnings growth (yoy) -0.04%
Balance Sheet
Total cash (mrq) 1.52B
Total cash per share (mrq) 157.19
Total debt (mrq) 3.06B
Total Debt/Equity (mrq) 30.91
Current ratio (mrq) 1.17%
Book value per share (mrq) 5.53
Cash Flow
Cash flow statement 3.03B
Levered free cash flow (LFCF) 2.1B
